Neurology·New York, NY

Icahn School of Medicine at Mount Sinai/West

Signal lift15%65%+50 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
230–264
p10 – p90
Sample N
658
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
0.8%
5 of 658 applicants
01Cohort funnelthis cycle
N = 658
Applied
658
100.0%
Invited
85
12.9%
Class size
5
0.8%
J-1 visaH-1B visaF-1 visaGraduated within 5 yearsAdvanced
Your fitIcahn School of Medicine at Mount Sinai/West Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at Icahn School of Medicine at Mount Sinai

Create free account

Who to contact

Training sites4 hospitals · New York
  • 1
    Mount Sinai West
    New York, NY
    Primary
  • 2
    Icahn School of Medicine at Mount Sinai
    New York, NY
    Sponsor
  • 3
    Mount Sinai Beth Israel
    New York, NY
    Participant
  • 4
    Mount Sinai Hospital
    New York, NY
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK230 – 264
180205230255280

Level 2 CE data not available

Interview rates
US MD
30%
US DO
12%
US IMG
1%
Non-US IMG
4%
Applicant origin
In-state
39%
Out-of-state
10%
Interview prepNeurology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesNeurology · 25-26
Save this program

Add Icahn School of Medicine at Mount Sinai/West to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Neurology.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.